Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Valent P, Akin C, Hartmann K, et al.
Cancer Res · 2017
Grade Bnarrative review
Key Findings
- ●Classification refinements from consensus group, WHO, and ECNM
- ●New treatment options including allogeneic HSCT and KIT D816V inhibitors
Referenced in (1 disease)
ID: pmid-28254862DOI: 10.1158/0008-5472.CAN-16-2234PMID: 28254862